AbCellera Biologics Inc.ABCLNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank71
3Y CAGR+25.5%
5Y CAGR+73.4%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+25.5%/yr
vs -24.0%/yr prior
5Y CAGR
+73.4%/yr
Recent deceleration
Acceleration
+49.5pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
15.7x
Strong expansion
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20250.11+119.7%
20240.05-7.6%
20230.05-2.6%
20220.05+75.7%
20210.03+350.8%
20200.01-97.7%
20190.29+83.2%
20180.16-